Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QSPC (Quantitative Systems Pharmacology and Chemistry) was a specialized boutique consultancy that provided high-level Quantitative Systems Pharmacology (QSP) services to the global pharmaceutical and biotechnology industries. The company focused on using mechanistic modeling and simulation to bridge the gap between drug discovery and clinical development, helping clients optimize dose selection, identify biomarkers, and predict clinical outcomes. Founded by industry experts Piet van der Graaf and Neil Benson, QSPC was recognized for its expertise in integrating systems biology with pharmacokinetics and pharmacodynamics. In July 2015, the company was acquired by Certara, a global leader in biosimulation, to bolster Certara's QSP capabilities and integrate specialized mechanistic modeling into its broader drug development platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QSPC.